Compound Detail
CHEMBL562
GRISEOFULVIN 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL562 |
| Name | GRISEOFULVIN |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | DDUHZTYCFQRHIY-RBHXEPJQSA-N |
| Therapeutic | ✓ Yes |
20
Targets
29
Activities
2
Assay Types
11
PK Parameters
20
Publications
30
Known Names
5
Indications
1
Mechanisms
Molecular Properties
352.8
MW (Da)
2.81
ALogP
6
HBA
0
HBD
71.1
PSA (Ų)
0.83
QED
0
Ro5 Violations
3
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1962 |
| Availability | Prescription |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Tubulin inhibitor | INHIBITOR | Tubulin | ✓ | ✓ |
Indications
Candidiasis Infections Tinea Tinea Capitis Tinea Pedis
ATC Classification
D01AA08
griseofulvin
Level 1: DERMATOLOGICALS
Level 2: ANTIFUNGALS FOR DERMATOLOGICAL USE
D01BA01
griseofulvin
Level 1: DERMATOLOGICALS
Level 2: ANTIFUNGALS FOR DERMATOLOGICAL USE
Activity Summary
IC50 28 meas. best 7.24
Kd 1 meas.
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Trichophyton mentagrophytes CHEMBL613162 | IC50 | 7.24 | 7.24 | 58.0 | 1 |
| Trichophyton rubrum CHEMBL612649 | IC50 | 6.42 | 6.42 | 380.0 | 1 |
| MDA-MB-435 CHEMBL614697 | IC50 | 5.19 | 5.19 | 6400.0 | 1 |
| NON-PROTEIN TARGET CHEMBL3879801 | IC50 | 5.19 | 4.76 | 6400.0 | 4 |
| Solute carrier family 22 member 1 CHEMBL5685 | IC50 | 5.14 | 5.14 | 7300.0 | 1 |
| V79 CHEMBL614074 | IC50 | 5.1 | 5.1 | 8000.0 | 1 |
| CCRF-CEM CHEMBL382 | IC50 | 5.0 | 5.0 | 10000.0 | 1 |
| Huh7.5.1 CHEMBL4483247 | IC50 | 5.0 | 5.0 | 10000.0 | 1 |
| MCF7 CHEMBL387 | IC50 | 4.86 | 4.86 | 13900.0 | 1 |
| MDA-MB-231 CHEMBL400 | IC50 | 4.75 | 4.65 | 18000.0 | 3 |
| U2OS CHEMBL615023 | IC50 | 4.65 | 4.65 | 22400.0 | 2 |
| Unchecked CHEMBL612545 | IC50 | 4.62 | 4.62 | 24000.0 | 1 |
| HeLa CHEMBL399 | IC50 | 4.6 | 4.44 | 25000.0 | 3 |
| Trypanosoma brucei rhodesiense CHEMBL612348 | IC50 | 4.4 | 4.4 | 39970.0 | 1 |
| OVCAR-3 CHEMBL614213 | IC50 | 4.31 | 4.31 | 48500.0 | 1 |
| Lanosterol 14-alpha demethylase CHEMBL3849 | IC50 | 4.3 | 4.3 | 50000.0 | 1 |
| Plasmodium falciparum CHEMBL364 | IC50 | 4.12 | 4.12 | 75120.0 | 1 |
| Human immunodeficiency virus 1 CHEMBL378 | IC50 | 4.06 | 4.06 | 87100.0 | 1 |
| Trypanosoma cruzi CHEMBL368 | IC50 | 4.06 | 4.06 | 87310.0 | 1 |
| Leishmania donovani CHEMBL367 | IC50 | 4.06 | 4.06 | 87030.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 8618.89 | ng.hr.mL-1 | Homo sapiens |
| AUC | 9023.71 | ng.hr.mL-1 | Homo sapiens |
| Cmax | 1702.53 | nM | Homo sapiens |
| Cmax | 1906.62 | nM | Homo sapiens |
| F | 95.0 | % | Homo sapiens |
| Fu | 0.216 | - | Rattus norvegicus |
| Fu | 0.427 | - | Mus musculus |
| T1/2 | 0.9667 | hr | Rattus norvegicus |
| T1/2 | 0.6167 | hr | Mus musculus |
| Tmax | 4.04 | hr | Homo sapiens |
| Tmax | 3.08 | hr | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine